Mini Review
Volume 3 Issue 7 - 2020
We Need More Aggressive Early Antenatal Care for Preeclampsia in Low Resource Primary Care Setting
Hermanto TJ*
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynaecology, Dr Soetomo General Hospital, Reproductive Health Magister Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
*Corresponding Author: Hermanto TJ, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynaecology, Dr Soetomo General Hospital, Reproductive Health Magister Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Received: May 15, 2020; Published: June 30, 2020




Abstract

Preeclampsia even though is still number one lady killer, until recently the pathophysiology is not completely understood and hence the management is only screening, low dose aspirin and induce labor. The problems are so big, with so little options: Screening is so expensive, multi-markers and not user friendly. Antenatal care are voluntary and if suffered from PE, the pregnancy will be induced at 37 week of pregnancy.

We propose new model of antenatal Care through aggressive management by active HRP findings, Low dose aspirin, closed mentoring and maternity waiting homes not waiting in the clinic and let the couples make voluntary antenatal care.

There will be 7 maternal characteristics items(age, previous PE, born as IUGR baby, first degree relative, interpregnancy interval, primpaternity, history of medical disorders) and two biophysical markers (Body Mass Index, Mean Arterial Pressure) as candidates for markers as high risk pregnancy for preeclampsia.

Keywords: Preeclampsia; Aggressive Management ANC; Active HRP Findings; Low Dose Aspirin; Closed Mentoring; Maternity Waiting Home

References

  1. Gawande A. “Being Mortal: Medicine and What Matters in the Edition”. Metropolitan Books (2014).
  2. NICE. “Hypertension in pregnancy. The management of hypertensive disorders during pregnancy”. London: National Collaborating Centre for Women’s and Children’s Health (2010).
  3. WHO. Recommendations for Prevention and treatment of pre-eclampsia and eclampsia. Geneve: WHO (2012).
  4. ACOG. “Hypertension in Pregnancy”. Washington: ACOG (2013).
  5. Kenny LC., et al. “Early Pregnancy Prediction of Preeclampsia in Nulliparous Women, Combining Clinical Risk and Biomarkers. The Screening for Pregnancy Endpoints (SCOPE) International Cohort Study”. Hypertension 64 (2014): 644-652.
  6. Magee LA., et al. “The FIGO Textbook of Pregnancy Hypertension An evidence-based guide to monitoring, prevention and management”. London: The Global Library of Women’s Medicine (2016).
  7. USPSTF. “Screening for Preeclampsia. 2017”. US Preventive Services Task Force Recommendation Statement (2017).
  8. Tan MY., et al. “Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE”. Ultrasound in Obstetrics and Gynecology 51 (2018): 743-750. 
  9. ACOG. “Practice Bulletin No 202. Gestational Hypertension and Preeclampsia”. Obstetrics and Gynecology 133.1 (2019).
  10. Poon LC., et al. “The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention”. International Journal of Gynecology and Obstetrics 145.1 (2019): 1-33.
  11. Levine RL and Lindheimer MD. “First Trimester Prediction of Early Preeclampsia - a Possibility at Last!” Hypertension 53.5 (2009): 747-748. 
  12. Ghojazadeh M., et al. “Prognostic risk factors for early diagnosing of Preeclampsia in Nulliparas”. Nigerian Medical Journal 54.5 (2013): 344-348. 
  13. Poon LCY and Nicolaides KH. “Early Prediction of Preeclampsia”. Obstetrics and Gynecology International (2014). 
  14. Bartsch E., et al. “Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies”. British Medical Journal 353 (2016): i1753. 
  15. Reddy M., et al. “How to perform first trimester combined screening for pre-eclampsia”. AJUM 21.4 (2018).
  16. Zhang J., et al. “Early prediction of preeclampsia and small for gestational-age via multi-marker model in Chinese pregnancies: a prospective screening study”. BMC Pregnancy and Childbirth 19 (2019): 304. 
  17. Norwitz ER and Bellussi F. “Early pregnancy prediction of preeclampsia”. UpToDate (2020). 
  18. Chien PFW., et al. “How useful is uterine artery Doppler flow velocimetry in the prediction of preeclampsia, IUGR and Perinatal death. An Overview”. BJOG: An International Journal of Obstetrics and Gynaecology 107.2 (2000): 196-208.
  19. Hermanto TJ. “Eligibility to Get Pregnant for Women with Heart Disease”. Surabaya: Seminar on Heart Disease in Pregnancy (2018).
  20. Hermanto TJ., et al. “Maternal Deaths at dr Soetomo Tertiary Hospital Surabaya 2019”. Old premise on the same problem: Too old, too late and too little. Under preparation for publication (2019).
  21. Sibai B., et al. “Pre-eclampsia”. Lancet 365 (2005): 785-799.
  22. Dekker G., et al. “The etiology of preeclampsia: the role of the father”. Journal of Reproductive Immunology (2011): 126-132.
  23. Dekker G. “Trying to understand preeclampsia. A rocky road”. Majalah Obstetric Genealogy 27.2 (2019): 45-48.
  24. Rana S., et al. “Preeclampsia: Pathophysiology, Challenges, and Perspectives”. Circulation Research 124 (2019): 1094-1112. 
  25. Karumanchi SA., et al. “Preeclampsia: Pathogenesis”. UpToDate (2020).
  26. Dekker G and Sibai B. “Primary, secondary, and tertiary prevention of pre-eclampsia”. The Lancet 357 (2001).
  27. August P and Jeyabalan A. “Preeclampsia: Prevention”. UpToDate (2020).
  28. Kosack CS., et al. “A guide to aid the selection of diagnostic test”. Bulletin of the World Health Organization 95 (2017): 639-645. 
  29. North RA., et al. “Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort”. British Medical Journal 342 (2011): d1875. 
  30. Nicolaides KH. “A model for a new pyramid of prenatal care based on the 11 to 13 weeks’ assessment”. Editorial Prenatal Diagnosis 31 (2011): 3-6. 
  31. Nicolaides KH. “Turning the Pyramid of Prenatal Care”. Fetal Diagnosis and Therapy 31 (2011): 3-6. 
  32. Baschat AA. “First-trimester screening for pre-eclampsia: moving from personalized risk prediction to prevention”. Editorial Ultrasound in Obstetrics and Gynecology 45 (2015): 119-129.
  33. Ghia T., et al. “Antenatal Care of Preeclampsia: From the Inverted Pyramid to the Arrow Model”. Fetal Diagnosis and Therapy 44 (2018): 81-84. 
  34. Wright A., et al. “Two-stage screening for preterm preeclampsia at 11-13 weeks’ gestation”. American Journal of Obstetrics and Gynecology 220 (2019): 197.
  35. Hermanto TJ. “OPROCOT (Out of the Box, Proactive, Comprehensive, Top Down) model to Reduce Maternal Mortality”. Jakarta: Term of Reference for Task force in Reducing Maternal Mortality (2014).
  36. Hermanto TJ., et al. “Term of Reference Bangkalan District Program in Reducing Maternal Mortality” (2014). 
  37. Hermanto TJ., et al. “Maternal and Neonatal Outcome in Women with Preeclampsia Screening Program at Mulyorejo and Kalijudan Health Centre Surabaya 2013-2015”. Under preparation for publisihing (2007).
  38. Kumaril N., et al. “Relationship between Maternal Age and Preeclampsia”. Journal of Dental and Medical Sciences (2016). 
  39. Robillard P-Y., et al. “Increased BMI has a linear association with late onset preeclampsia: A population-based study”. PLoS ONE 14.10 (2019): e0223888. 
  40. Hernández-Díaz S., et al. “Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study”. British Medical Journal (2009): 338. 
  41. Carr DB., et al. “A sister's risk: Family history as a predictor of preeclampsia”. Am JOG 193 (2005): 965-972.
  42. Sherf Y., et al. “Like mother like daughter: low birth weight and preeclampsia tend to reoccur at the next generation”. Journal of Maternal-Fetal and Neonatal Medicine 32.9 (2019): 1478-1484.
  43. Andraweera PH., et al. “Effect of Birth Weight and Early Pregnancy BMI on Risk for Pregnancy Complications”. Obesity (2018): 1-8. 
  44. Skjærven R., et al. “The Interval Between Pregnancies and The Risk of Preeclampsia”. The New England Journal of Medicine 346.1 (2002).
  45. Hercus A., et al. “Primipaternity and birth interval; independent risk factors for preeclampsia”. The Journal of Maternal-Fetal and Neonatal Medicine (2018). 
  46. Kho EM., et al. “Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome”. Journal of Reproductive Immunology 82 (2009): 66-73.
  47. Chung JGY., et al. “Gestational weight gain and adverse pregnancy outcomes in a nulliparous cohort”. European Journal of Obstetrics and Gynecology and Reproductive Biology (2012).
  48. Shao Y., et al. “Pre-pregnancy BMI, gestational weight gain and risk of preeclampsia: a birth cohort study in Lanzhou, China”. BMC Pregnancy and Childbirth 17 (2017): 400.
  49. Poon LCY., et al. “Mean Arterial Pressure at 11 to 13 Weeks in the Prediction of Preeclampsia”. Hypertension (2008). 
  50. Gallo D., et al. “Prediction of Preeclampsia by Mean Arterial Pressure at 11-13 and 20-24 Weeks Gestation”. Fetal Diagnosis and Therapy 36 (2014): 28-37. 
  51. Wright A., et al. “Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history”. Ultrasound in Obstetrics and Gynecology 45 (2015): 698-706. 
  52. Tayyar A., et al. “Mean arterial pressure at 12, 22, 32 and 36weeks‟ gestation in screening for pre-eclampsia”. Ultrasound in Obstetrics and Gynecology 47 (2016): 573-575.
  53. Hyre A. Mystery of Maternal Mortality in Indonesia. Univeristy of Colorado.
  54. Wild K., et al. “The tyranny of distance: maternity waiting homes and access to birthing facilities in rural Timor-Leste”. Bulletin of the World Health Organization 90 (2012): 97-103. 
  55. Vermeiden T., et al. “Facotros associated with intended use of a maternity waiting home in Southern Ethiopia: a community-based cross-sectional study”. BMC Pregnancy and Childbirth 18 (2018): 38. 
  56. Ratnaningsih T., et al. “Mentoring of Pregnant Women at High Risk Program (Gerdaristi) to Reduce Maternal and Infant Mortality in Nganjuk, East Java”. Journal of Maternal and Child Health 1.4 (2016): 268-276. 
Citation: Hermanto TJ. “We Need More Aggressive Early Antenatal Care for Preeclampsia in Low Resource Primary Care Setting”. EC Clinical and Medical Case Reports 3.7 (2020): 188-197.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 22, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk